Table 1.
Product/Agent | Indications | Status | Company | References |
---|---|---|---|---|
siEVI1-ELP | Various cancers (breast, ovarian, pancreatic, and lung) | Preclinical | PeptiMed | [139] |
Liposome-ELP conjugates | Breast cancer | Preclinical | Samsung | [98] |
VIP-ELP (Vasomera™) | Pulmonary arterial hypertension, cardiomyopathies, cystic fibrosis | Phase I | PhaseBio | [130-133, 140, 141] |
GLP1-ELP (Glymera™) | Type II diabetes | Phase IIB | PhaseBio | [61, 91, 138] |